High dose chemotherapy for the treatment of breast cancer: What have we learned?KK Fields; GJ Elfenbein; JB Perkins; JS Partyka; H. Lee Moffitt · 1996

NIH Consensus Breast Cancer ConferenceBearman, Scott I. · Oncology Times · 2001

Veno-occlusive disease of the liverBearman, Scott I. · Current Opinion in Oncology · 2000

Use of stem cell factor to mobilize hematopoietic progenitorsBearman, Scott I. · Current Opinion in Hematology · 1997

Regimen-related toxicities of blood and marrow transplantationBearman, Scott I. · Current Opinion in Organ Transplantation · 1998

Peripheral blood stem cell transplantation in breast cancerElizabeth J. Shpall; Roy B. Jones; Scott I. Bearman; Pablo J. Cagnoni; Yago Nieto; Ian K. McNiece · 1999

Prevention and Treatment of Hepatic Venocclusive Disease after High-Dose Cytoreductive TherapyRichardson, Paul; Bearman, Scott I. · Leukemia & Lymphoma · 1998

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancerRoy B. Jones; Steven Matthes; Christopher Dufton; Scott I. Bearman; Salomon M. Stemmer; Susan Meyers; Elizabeth J. Shpall · 1993

The First 1000 Dendritic Cell VaccineesRidgway, Derry · Cancer Investigation · 2003

RAS: Target for Cancer TherapySaxena, Nandita; Lahiri, Sitanshu Sekhar; Hambarde, Shashank; Tripathi, Rajendra Prasad · Cancer Investigation · 2008

New Opportunities in Chemoprevention ResearchKucuk, Omer · Cancer Investigation · 2002

Dendritic Cell Vaccines—Hopeful or Hopeless?Slovin, Susan F. · Cancer Investigation · 2003

Breast MRI: State of the ArtVandermeer, Fauzia Q.; Bluemke, David A. · Cancer Investigation · 2007

Human Tumor Lines for Cancer ResearchFogh, Jørgen · Cancer Investigation · 1986

New and Emerging Radiosensitizers and RadioprotectorsSpalding, Aaron C.; Lawrence, Theodore S. · Cancer Investigation · 2006

Pharmacology and Pharmacogenetics of Chemotherapeutic AgentsDawood, Shaheenah; Leyland-Jones, Brian · Cancer Investigation · 2009